Gynecologic oncology group trials in uterine corpus malignancies: recent progress.
10.3802/jgo.2008.19.4.218
- Author:
David Scott MILLER
1
;
Louise P KING
Author Information
1. Department of Obstetrics and Gynecology, University of Texas Southwestern Medical Center, Dallas, TX, USA. David.Miller@UTSouthwestern.edu
- Publication Type:Clinical Trial ; Review
- Keywords:
Endometrial neoplasm;
Carcinosarcoma;
Clinical trial
- MeSH:
Carcinosarcoma;
Drug Therapy, Combination;
Endometrial Neoplasms;
Female
- From:Journal of Gynecologic Oncology
2008;19(4):218-222
- CountryRepublic of Korea
- Language:English
-
Abstract:
The Gynecologic Oncology Group (GOG) has conducted multiple trials related to malignancies of the uterine corpus. Recently, several of these trials have been presented and/or published. Areas of focus included the feasibility of laparoscopic staging for endometrial cancer, the adjuvant management of locally advanced endometrial cancer, whole abdominal irradiation in maximally resected advanced endometrial carcinoma, and combination chemotherapy regimens for stage I and II carcinosarcoma after primary surgery and for advanced or recurrent carcinosarcoma. This article will discuss the background and details of each of these important advances.
